IPR Tracker: IPR2015-01514 and IPR2015-01517 (Amgen Inc.) (U.S. Patent Nos. 8,916,157 and 8,916,158)

Biosimilar News  •  PTAB + IPR

 

IPR2015-01514 (Amgen Inc.) (U.S. Patent No. 8,916,157)

  • Petitioner: Amgen Inc.
  • Patent: U.S. Patent No. 8,916,157
  • Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
  • Patent Owner: AbbVie Biotechnology Ltd.

IPR2015-01517 (Amgen Inc.) (U.S. Patent No. 8,916,158)

  • Petitioner: Amgen Inc.
  • Patent: U.S. Patent No. 8,916,158
  • Patent Title: Formulation of human antibodies for treating TNF-α associated disorders
  • Patent Owner: AbbVie Biotechnology Ltd.
Download PDF

Tagged with 

Comments are closed.